patents.google.com

ID28441A - THERAPY TO IMPROVE CONSCIOUSNESS - Google Patents

  • ️Thu May 24 2001

ID28441A - THERAPY TO IMPROVE CONSCIOUSNESS - Google Patents

THERAPY TO IMPROVE CONSCIOUSNESS

Info

Publication number
ID28441A
ID28441A IDW20010828A ID20010828A ID28441A ID 28441 A ID28441 A ID 28441A ID W20010828 A IDW20010828 A ID W20010828A ID 20010828 A ID20010828 A ID 20010828A ID 28441 A ID28441 A ID 28441A Authority
ID
Indonesia
Prior art keywords
therapy
improve consciousness
consciousness
improve
Prior art date
1998-10-16
Application number
IDW20010828A
Other languages
Indonesian (id)
Inventor
Paul L I Denijs
Win L J Parys
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1998-10-16
Filing date
1999-10-12
Publication date
2001-05-24
1999-10-12 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
2001-05-24 Publication of ID28441A publication Critical patent/ID28441A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
IDW20010828A 1998-10-16 1999-10-12 THERAPY TO IMPROVE CONSCIOUSNESS ID28441A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98203454 1998-10-16

Publications (1)

Publication Number Publication Date
ID28441A true ID28441A (en) 2001-05-24

Family

ID=8234219

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010828A ID28441A (en) 1998-10-16 1999-10-12 THERAPY TO IMPROVE CONSCIOUSNESS

Country Status (20)

Country Link
EP (1) EP1121131A2 (en)
JP (1) JP2002527469A (en)
KR (1) KR20010072878A (en)
CN (1) CN1367697A (en)
AU (1) AU6472799A (en)
BG (1) BG105302A (en)
BR (1) BR9914419A (en)
CA (1) CA2345767A1 (en)
EE (1) EE200100136A (en)
HK (1) HK1039745A1 (en)
HR (1) HRP20010262A2 (en)
HU (1) HUP0103781A3 (en)
ID (1) ID28441A (en)
IL (1) IL142588A0 (en)
NO (1) NO20011403L (en)
PL (1) PL348107A1 (en)
SK (1) SK4592001A3 (en)
TR (1) TR200101082T2 (en)
WO (1) WO2000023057A2 (en)
ZA (1) ZA200103081B (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0102841D0 (en) * 2001-02-05 2001-03-21 Novartis Ag Organic compounds
AU2006201188B2 (en) * 2001-02-05 2007-11-15 Novartis Ag New use of iloperidone
CN1578664A (en) * 2001-10-30 2005-02-09 诺瓦提斯公司 Depot formulations of iloperidone and a star polymer
GB0216416D0 (en) 2002-07-15 2002-08-21 Novartis Ag Organic compounds
WO2004084905A2 (en) * 2003-03-24 2004-10-07 University Of Florida Use of 5-ht2c receptor activity affecting compounds for treating idiopathic hyperhidrosis and associated conditions
TW200501962A (en) * 2003-04-01 2005-01-16 Novartis Ag Use of carbamazepine derivatives for the treatment of agitation in dementia patients
WO2006065233A1 (en) * 2004-12-10 2006-06-22 Abbott Laboratories Fused bicycloheterocycle substituted quinuclidine derivatives
WO2005065645A2 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Donepezil formulations
WO2008055945A1 (en) 2006-11-09 2008-05-15 Probiodrug Ag 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases
DK2091948T3 (en) 2006-11-30 2012-07-23 Probiodrug Ag Novel inhibitors of glutaminyl cyclase
CA2679446C (en) 2007-03-01 2016-05-17 Probiodrug Ag New use of glutaminyl cyclase inhibitors
DK2142514T3 (en) 2007-04-18 2015-03-23 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
MX2007008642A (en) * 2007-07-16 2009-02-25 World Trade Imp Export Wtie Ag Pharmaceutical composition comprising the combination of a benzisoxazolic derived agent and a reversible inhibiting agent of the cholinesterase enzyme prescribed for the control and treatment of psychotic disorders and dementias.
AU2011215870B2 (en) 2010-02-09 2016-01-28 The Johns Hopkins University Methods and compositions for improving cognitive function
EP2542549B1 (en) 2010-03-03 2016-05-11 Probiodrug AG Inhibitors of glutaminyl cyclase
EP2545047B9 (en) 2010-03-10 2015-06-10 Probiodrug AG Heterocyclic inhibitors of glutaminyl cyclase (qc, ec 2.3.2.5)
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
US8530670B2 (en) 2011-03-16 2013-09-10 Probiodrug Ag Inhibitors
JP6440625B2 (en) 2012-11-14 2018-12-19 ザ・ジョンズ・ホプキンス・ユニバーシティー Methods and compositions for treating schizophrenia
CN105142623A (en) 2013-03-15 2015-12-09 艾吉因生物股份有限公司 Methods and compositions for improving cognitive function
EP3827820A1 (en) 2013-03-15 2021-06-02 The Johns Hopkins University Brivaracetam for improving cognitive function
EA034167B8 (en) 2015-05-22 2021-04-27 Эйджинбайо, Инк. Extended release pharmaceutical compositions of levetiracetam
ES2812698T3 (en) 2017-09-29 2021-03-18 Probiodrug Ag Glutaminyl cyclase inhibitors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
US5312817A (en) * 1991-05-14 1994-05-17 Ernir Snorrason Treatment of fatigue syndrome
CA2300148C (en) * 1997-08-11 2009-06-23 University Of South Florida Nicotine antagonists for nicotine-responsive neuropsychiatric disorders
NZ508160A (en) * 1998-04-14 2004-01-30 Gen Hospital Corp Methods for treating neuropsychiatric disorders

Also Published As

Publication number Publication date
HUP0103781A3 (en) 2003-09-29
HK1039745A1 (en) 2002-05-10
NO20011403D0 (en) 2001-03-20
HRP20010262A2 (en) 2002-06-30
PL348107A1 (en) 2002-05-06
WO2000023057A3 (en) 2000-07-27
EE200100136A (en) 2002-06-17
CA2345767A1 (en) 2000-04-27
BG105302A (en) 2001-11-30
AU6472799A (en) 2000-05-08
HUP0103781A2 (en) 2002-03-28
CN1367697A (en) 2002-09-04
TR200101082T2 (en) 2001-09-21
SK4592001A3 (en) 2001-12-03
ZA200103081B (en) 2002-07-12
NO20011403L (en) 2001-03-20
BR9914419A (en) 2001-06-26
EP1121131A2 (en) 2001-08-08
KR20010072878A (en) 2001-07-31
WO2000023057A2 (en) 2000-04-27
JP2002527469A (en) 2002-08-27
IL142588A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
ID28441A (en) 2001-05-24 THERAPY TO IMPROVE CONSCIOUSNESS
ID28111A (en) 2001-05-03 METHODS TO IMPROVE SKIN HEALTH
ID27841A (en) 2001-04-26 THERAPEUTIC BIARILS
ID24314A (en) 2000-07-13 PLACE TO PLACE FAST-APPROXIMATELY
ID19875A (en) 1998-08-13 MODIFIED POLIOLEFIN ACCORDING TO REOLOGY
NO20004133D0 (en) 2000-08-18 Antibodies to human CD40
DE69524193D1 (en) 2002-01-10 MASSAGER
FI970762L (en) 1997-02-24 Spiroazabicyclic compounds useful in therapy
ID24118A (en) 2000-07-06 COMBINED THERAPY
DE69931855D1 (en) 2006-07-27 skin preparation
ID24275A (en) 2000-07-13 COMBINATION THERAPY
DE69921571D1 (en) 2004-12-09 MASSAGER
DE69514764D1 (en) 2000-03-02 Massager
FI973826L (en) 1999-03-30 Programs to run
ID24759A (en) 2000-08-03 METHODS TO IMPROVE BONE VOLUME
DK1019042T3 (en) 2003-08-25 Compounds with anti-first-pass effect
KR980000798U (en) 1998-03-30 Simple to use moxa moxa
MD281F1 (en) 1995-09-30 Magnetodynamic massage
KR960013388U (en) 1996-05-17 Acupressure
KR960000327U (en) 1996-01-17 How to make fresh acupuncture without disease
KR950032251U (en) 1995-12-14 Sauna structure for sauna
KR960025637U (en) 1996-07-22 Easy to adjust connector
KR950024525U (en) 1995-09-13 Acupuncture
KR960009986U (en) 1996-04-12 Massager
IT1285976B1 (en) 1998-06-26 DEVICE TO IMPROVE BREATHING